Aptorum Group
Open
$0.89
Prev. Close
$0.89
High
$0.89
Low
$0.89
Market Snapshot
$6.36M
-2.64
$1.29M
1
Aptorum Group Ltd. is a pharmaceutical company, which engages in the discovery, development, and commercializing of therapeutic assets to treat diseases with unmet medical needs. Its lead projects are ALS-4, SACT-1 and PathsDx Test. ALS-4 is a small drug molecule which appears to target the products produced by bacterial genes that facilitate the successful colonization and survival of the bacterium in the body or that cause damage to the body's systems. SACT-1 is the first repurposed drug candidate to be developed under the Smart-ACT drug discovery platform. The firm's pipeline is also enriched through the co-development of PathsDx Test, a molecular-based rapid pathogen identification and detection diagnostics technology, with Accelerate Technologies Pte Ltd, the commercialization arm of the Singapore's Agency for Science, Technology and Research.
emptyResult
Aptorum Group Ltd. is a pharmaceutical company, which engages in the discovery, development, and commercializing of therapeutic assets to treat diseases with unmet medical needs. Its lead projects are ALS-4, SACT-1 and PathsDx Test. ALS-4 is a small drug molecule which appears to target the products produced by bacterial genes that facilitate the successful colonization and survival of the bacterium in the body or that cause damage to the body's systems. SACT-1 is the first repurposed drug candidate to be developed under the Smart-ACT drug discovery platform. The firm's pipeline is also enriched through the co-development of PathsDx Test, a molecular-based rapid pathogen identification and detection diagnostics technology, with Accelerate Technologies Pte Ltd, the commercialization arm of the Singapore's Agency for Science, Technology and Research.
Recently from Cashu
Aptorum Group Advances SAct-1 Antibiotic to Combat Drug-Resistant Infections
Aptorum Group Advances in Antimicrobial Drug Development Aptorum Group, a biopharmaceutical company focused on developing innovative therapeutics, makes significant strides in the realm of antimicrobi…
Please provide the content you would like summarized, and I'll create a title for you.
Please provide the text or key details from the article you would like me to summarize, and I will be happy to help you create a summary.
Clarification Needed on Recent Developments Involving Aptorum Group
It seems there was a misunderstanding, as I do not have the actual content from Aptorum Group to summarize. If you could provide the specific text or details regarding the recent developments involvin…
Aptorum Group Experiences Volatile Trading Amidst Significant Stock Fluctuations
Aptorum Group Faces Volatile Trading Amid Business Developments Aptorum Group Limited is currently navigating a highly volatile trading environment, marked by significant fluctuations in its stock pri…